Immunovia AB and the Knight Cancer Institute at Oregon Health & Science University formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer.
Merck and Bionomics Limited extended their strategic collaboration for the discovery and development of drug candidates for the treatment of chronic and neuropathic pain.
FDA granted a Breakthrough Therapy designation to abemaciclib, a cyclin-dependent kinase 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive advanced or metastatic breast cancer.
SWOG and its charitable arm, The Hope Foundation, are providing $125,000 to five Department of Veterans Affairs medical centers. Under the new VA Integration Support Program, each VA medical center will receive $25,000 in seed funding to help them enroll veterans in trials run by SWOG and other members of the NCI National Clinical Trials... […]
THE NOBEL PRIZE IN CHEMISTRY for 2015 was awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar, for their mechanistic studies of DNA repair, by the Royal Swedish Academy of Sciences.
THE ONCOLOGY NURSING SOCIETY and Clinical Care Options LLC partnered to develop evidence-based resources, with the goal of creating a comprehensive self-study online reference and a fully searchable point-of-care decision support resource developed specifically for oncology nurses. The program is led by Editors-in-Chief Dawn Camp-Sorrell and Rebecca Hawkins. The inPractice technology platform contains original content,... […]
MEMORIAL SLOAN KETTERING CANCER CENTER and Cornell University are opening a new $10 million Center of Cancer Nanotechnology Excellence. The MSKCC-Cornell Center for Translation of Cancer Nanomedicines is funded with an $8.2 million grant from the NCI Alliance for Nanotechnology in Cancer and more than $1.9 million from MSKCC. The center—which will have one facility... […]
NYU LANGONE MEDICAL CENTER established a program in biologics research, appointing Shohei Koide to lead the new initiative. Koide will join NYU Langone March 1, 2016 as director of cancer biologics at the Laura and Isaac Perlmutter Cancer Center. “No other academic medical institution on the East Coast has a major presence in biologics research,”... […]
VICTORIA SEEWALDT was named the Ruth Ziegler Chair in Population Sciences at City of Hope. Seewaldt will also serve as the associate director of the comprehensive cancer center. Previously, she was a professor of medicine at Duke University and leader of the Comprehensive Cancer Breast and Ovarian Cancer Program. She also founded the institution’s community... […]
Centers for Medicare and Medicaid Services issued updated pricing determinations for the Clinical Laboratory Fee Schedule, which reversed a payment cut for the Oncotype DX breast cancer test.
